|
|
||||||||
1
Nephrology Research and Training Center, Comprehensive Cancer Center, and Cell Adhesion and Matrix Research Center, Division of Nephrology, Department of Medicine and Department of Physiology and Biophysics, University of Alabama at Birmingham, 35294-0007; and Department of Veterans Affairs Medical Center, Birmingham, Alabama 35233
| |
ABSTRACT |
|---|
|
|
|---|
Dietary salt controls production of nitric oxide (NO), a potent
paracrine relaxation factor involved in glomerular filtration and salt
excretion. We hypothesized that glomerular NO production was enhanced
through endothelial nitric oxide synthase (NOS3). Rats in metabolic
cages were studied after 4 days on 0.3% (Lo-salt) or 8.0% (Hi-salt)
NaCl diet. Steady-state mRNA and protein levels of NOS3 and
calcium-dependent NO production of isolated glomeruli from Hi-salt
animals were greater than those values observed in glomeruli from
Lo-salt rats. Because dietary salt enhanced glomerular production of
transforming growth factor-
1 (TGF-
1) [W.-Z. Ying and P. W. Sanders. Am. J. Physiol. 274 (Renal Physiol. 43): F635-F641, 1998], studies were then conducted to examine the interaction between NOS3 and TGF-
1. Glomerular steady-state levels of mRNA of
NOS3 and TGF-
1 directly correlated
(r2 = 0.946;
P < 0.0001). A neutralizing antibody
to TGF-
reduced NOS3 protein and NO production in cultured glomeruli
from Hi-salt animals to levels seen in the Lo-salt glomeruli. Thus
dietary salt increased glomerular expression of TGF-
1, which in turn augmented NO production through NOS3.
sodium chloride; nitric oxide; glomerulus; endothelial nitric oxide
synthase; transforming growth factor-
1
| |
INTRODUCTION |
|---|
|
|
|---|
TO EXCRETE SALT in appropriate amounts, several systems monitor variations in dietary salt intake and effect changes in renal salt excretion. The renin-angiotensin-aldosterone axis is one such system. Recently, another factor, nitric oxide (NO), has been suggested to play an important role in salt balance (8-10, 16, 28, 33, 37). Dietary salt controls NO production in vivo (8, 33). Tolins and associates (36) demonstrated further that endogenous NO production was an important factor determining salt excretion and subsequent blood pressure response to a high-salt diet.
NO is a potent paracrine dilator. In the glomerulus, the mesangial cell is a principal site of action of NO. Mesangial cells attach to the basement membrane of the capillary to form a biomechanical unit (31, 32). Blantz and associates (3) demonstrated the importance of the mesangial cell in regulation of glomerular hemodynamics. These micropuncture studies of rats with mesangiolysis failed to demonstrate the standard increase in single-nephron glomerular filtration rate that occurs with plasma volume expansion. In addition, the decrease in glomerular ultrafiltration coefficient (Kf) that normally occurs with infusion of angiotensin II was not seen (3). By use of inhibitors of nitric oxide synthase (NOS), Deng and Baylis (15) showed that NO also regulates Kf, presumably through relaxation of the mesangial cell to increase the effective filtering surface area of the glomerulus. Because an increase in dietary salt expands plasma volume (14), we hypothesized that an expected compensation is augmented glomerular production of NO. The current studies sought to determine whether glomerular production of NO was enhanced by an increase in dietary salt and further to identify the potential mechanism involved.
| |
METHODS |
|---|
|
|
|---|
Animal preparation. Studies were
conducted using 48 male Sprague-Dawley rats, 28 days of age, obtained
from Charles River Laboratories (Wilmington, MA). Animals were chosen
at this age because of our previous experience which showed normal
renal function and blood pressure responses to dietary salt
over 2 wk of observation (8). The rats were housed under standard
conditions and given 0.3% NaCl diet (AIN-76A with 0.3% NaCl; Dyets,
Bethlehem, PA) and water ad libitum for 4 days before initiating the
experiment. The animals were then placed in metabolic cages and allowed
free access to water and rat diet, which contained either 0.3% (termed "Lo-salt" group) or 8.0% (AIN-76A with 8.0% NaCl, Dyets; termed "Hi-salt" group) NaCl. Urine was collected under oil to prevent desiccation. Food consumption, urine flow, and body weight were recorded daily, and the experiment was concluded after the 4th day. The
collected urine sample from each rat was filtered to remove any
particulate matter and centrifuged at 325 g for 2 min at 4°C. The
supernatant was collected and immediately frozen at
80°C
until use. Urine samples were analyzed for sodium and potassium, using
flame photometry (model IL-943; Instrumentation Laboratories, Lexington, MA). On the day of study, rats were anesthetized with a
pentobarbital sodium (50 mg/kg ip) injection. Both kidneys were harvested under sterile conditions for isolation of glomeruli for in
vitro incubation experiments and obtaining protein for Western blotting
and total RNA for Northern hybridization.
Isolation of glomeruli. Glomeruli were
isolated using a graded sieving technique. This protocol has been shown
to produce pure and viable glomeruli for study of transforming growth
factor-
(TGF-
) and NO production (6, 20, 35, 38). The kidneys were perfused in situ through the aorta with cold isotonic heparinized saline until blanched (50-60 ml saline over 2 min). The renal cortices from each rat were individually dissected and minced to a
pastelike consistency. The homogenate was passed successively through a
106-µm metal sieve that excluded blood vessels and a 75-µm nylon
sieve that retained the glomeruli and allowed cells and small tubular
segments to pass through. Glomeruli were washed three times with
ice-cold PBS at 120 g for 5 min. The
pelleted glomeruli were then used as described below for incubation
studies, Western blotting, and Northern analysis. All
glomerular preparations consisted of more than 95% glomeruli
with minimal tubular contamination, as assessed visually at ×40
magnification.
Glomerular incubation studies. The
pelleted glomeruli were resuspended at 5 × 103 glomeruli/ml of serum-free
medium (RPMI 1640; Life Technologies, Grand Island, NY). Simultaneously
obtained samples of glomeruli from Hi-salt and Lo-salt animals were
placed in 24-well plates. Samples were initially incubated with medium
alone or medium that contained 3 mM tetraethylammonium chloride (TEA;
Sigma Chemical, St. Louis, MO) or 10 µg/ml rabbit polyclonal antibody
that specifically neutralizes TGF-
(catalog no. AB-100-NA; R & D
Systems, Minneapolis, MN) in serum-free RPMI media at 37°C. TEA in
this dose specifically inhibits potassium channels but is relatively
nonselective (7, 12, 13, 25, 26) and has been used previously to
examine TGF-
production by endothelial cells (25). In some
experiments, nonspecific rabbit IgG (10 µg/ml; Southern Biotechnology
Associates, Birmingham, AL) was added as another control. After a
30-min incubation period, the medium was removed and replaced with
serum-free medium alone or serum-free medium that contained the same
concentrations of TEA or neutralizing antibody. Human TGF-
1
(0-10 ng/ml, R & D Systems) was added in some experiments. As
described by others (18), to determine calcium-dependent NO production,
some samples of each preparation also contained the calcium ionophore
A-23187 (1 µM, Sigma Chemical). All samples were incubated for 24 h
at 37°C; samples of conditioned media were then harvested stored at
20°C until assayed for nitrate, nitrite, and TGF-
1. The
glomeruli were then processed for total protein assay and Western
blotting, as described below.
Measurement of glomerular NO production. Concentrations of nitrate and nitrite, collectively termed NOx, in conditioned media were determined by methods described previously (10). All reagents were from Sigma. To determine NOx concentration, samples of medium, diluted 1:5 in deionized water and sodium nitrate standards (0-200 µM), were simultaneously reduced for 1 h at 37°C by Escherichia coli (ATCC no. 25922; American Type Culture Collection, Rockville, MD) grown previously under anerobic conditions. After centrifugation for 10 min at 1,000 g, 50 µl of supernatant were added to 50 µl of 1.0% sulfanilamide in 30% acetic acid and 50 µl of 0.1% N-(1-naphthyl)ethylenediamine dihydrochloride in 60% acetic acid (Griess reagent). After mixing, the optical density was read at 540 nm, using a microplate reader (THERMOmax; Molecular Devices, Menlo Park, CA).
TGF-
1 immunoassay.
Active TGF-
1 in the medium was determined using an enzyme
immunoassay (TGF-
1 Emax
ImmunoAssay System; Promega, Madison, WI), following the protocol
provided by the manufacturer. Briefly, plates containing 96 flat-bottom
wells (Falcon; Becton Dickinson, Oxnard, CA) were coated overnight at 4°C with 100 µl of anti-TGF-
1 monoclonal antibody diluted
1:1,000 in buffer that contained 0.025 M sodium bicarbonate and 0.025 M
sodium carbonate, pH 9.7. Thereafter, unbound sites in the wells were
blocked using 270 µl of the blocking reagent supplied in the kit for
2 h at room temperature, then 100 µl of undiluted medium or TGF-
1
standard in sample buffer were added to wells. After incubation for 3 h
at room temperature with vigorous shaking, the wells were washed five
times with TBST wash buffer (20 mM Tris · HCl, pH
7.6, 150 mM NaCl, and 0.05% Tween 20), then 100 µl of polyclonal
anti-TGF-
1 diluted in sample buffer were added. The plates were
again incubated overnight at 4°C. After five washes with TBST
buffer, wells were filled with 100 µl of antibody conjugated with
horseradish peroxidase and incubated for 3 h at room temperature with
shaking. After additional washes as in the previous steps, color was
developed by adding 100 µl of peroxidase substrate in 3,3',5,5'-tetramethylbenzidine solution. After an ~10-min
incubation at room temperature, 100 µl of 1 M phosphoric acid were
added to stop the color reaction. Optical density was determined at 450 nm using a microplate reader
(THERMOmax, Molecular Devices). Standards were performed in duplicate using TGF-
1 (7.8-1,000 pg/ml in sample buffer) and were used to construct standard curves from
which the concentrations of the samples were determined.
Western blot analysis. Glomeruli that were freshly isolated from the Hi-salt and Lo-salt rats and glomeruli that were treated as described in the incubation studies described above were washed with PBS, then centrifuged at 200 g for 5 min at 4°C. The pellet was dissolved in RIPA buffer (in mM: 50 Tris · HCl, 150 NaCl, 1 disodium EDTA, 0.1 EGTA, 1.0% Nonidet P-40, 0.1% SDS, and 0.5% sodium deoxycholate). Phenylmethylsulfonyl fluoride (PMSF, 1 mM), 10 µg/ml aprotinin, and 10 µg/ml leupeptin were added as protease inhibitors. All of these inhibitors were from Sigma Chemical. Total protein of each sample was determined using a kit (Micro bicinchoninic acid protein assay reagent kit; Pierce, Rockford, IL), and the volume of each sample was adjusted to allow loading of 30 µg into each well. The samples were boiled in SDS-Laemmli sample buffer for 5 min, then the proteins were resolved using a 8% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane. After incubation in blocking buffer (10 mM Tris, pH 7.5, containing 5% nonfat dry milk, 100 mM NaCl, and 0.1% Tween 20), the membranes were probed with anti-human NOS3 monoclonal antibody (Transduction Laboratories, Lexington, KY), 1:1,000 dilution, in blocking buffer for 2 h at room temperature. The membranes were then washed five times with TBST and were incubated with horseradish peroxidase-conjugated anti-IgG antibody (Bio-Rad, Hercules, CA), 1:2,000 dilution, in blocking buffer. After three additional washes using TBST, the membrane was developed using ECL enhanced chemiluminescence Western blotting system and Hyperfilm (Amersham International, Buckinghamshire, UK). The films were scanned using a densitometer to quantify NOS3 (model 620 Video Densitometer, Bio-Rad).
Northern hybridization. Total RNA was
isolated from freshly isolated glomeruli in standard fashion by
single-step method of acid guanidinium thiocyanate-phenol-chloroform
extraction (11). The concentration and purity of RNA in each sample
were determined using optical density at 260 and 280 nm. Twenty
micrograms of total RNA from each sample was resolved in 1.0% agarose
gels containing 2.2 M formaldehyde and 0.2 M MOPS, pH 7.0, then
transferred to a nylon membrane (Genescreen Plus Hybridization Transfer
Membrane; NEN Life Science Products, Boston, MA) by vacuum blotting
(model 785, Bio-Rad) for 2 h in 10× standard sodium citrate
(SSC). Nucleic acids were cross-linked by ultraviolet irradiation
(Stratagene, La Jolla, CA). The membranes were prehybridized for 20 min
at 68°C in standard hybridization solution (QuikHyb, Stratagene). They were then hybridized at 68°C for 4 h with cDNA probes for rat
TGF-
1 (kindly provided by Dr. Thomas S. Winokur, University of
Alabama at Birmingham) and for bovine NOS3 (generously provided by Dr.
William C. Sessa, Yale University School of Medicine). The cDNA probes,
which consisted of an ~1-kb fragment that was produced by digestion
of the TGF-
1 plasmid with Hind III and Xba I and included the entire coding
region (17) and an ~4-kb fragment produced by digestion of the NOS3
plasmid with EcoR I, were labeled with
[
-32P]dCTP by random oligonucleotide priming (Prime-a-Gene Labeling System, Promega). The blots were washed
in 2× SSC with 0.1% SDS at room temperature for 30 min and in
0.1× SSC with 0.1% SDS at 60°C for 20-30 min. Membranes were exposed to XAR-5 film (Kodak) at
80°C. The blots were
then stripped in solution containing 1 mM Tris · HCl,
pH 8.0, 0.1 mM EDTA and 0.1× Denhardt's at 75°C for 2 h and
rehybridized with human glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) probe obtained through the American Type Culture Collection.
Autoradiographs were scanned using a densitometer (model 620 Video
Densitometer, Bio-Rad). The density of the GAPDH band in the same lane
was used to normalize mRNA loading. For quantification, densities of
the bands of TGF-
1 and NOS3 were individually divided by the density of band for GAPDH in the same lane.
Statistical analysis. All data are presented as means ± SE. Significant difference among data sets was determined using either the unpaired t-test or one-way analysis of variance with standard posthoc testing (Statview, version 4.5; Abacus Concepts, Berkeley, CA), where appropriate. P < 0.05 was statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Mean body weight, food intake, urinary flow rate, urinary sodium excretion rate, and urinary potassium excretion rate of the 32 rats in this study were shown in Table 1. As expected, urinary flow rate and urinary sodium and potassium excretion rates of the Lo-salt group were less (P < 0.05) than the corresponding Hi-salt group.
|
Steady-state mRNA and protein levels of NOS3 were determined using
freshly isolated glomeruli from rats on the 8.0% and 0.3% NaCl diets.
Northern analysis and Western blotting confirmed increased expression
of NOS3 in glomeruli from the Hi-salt group (Figs. 1 and
2). Mean steady-state mRNA of TGF-
1
was also greater (0.632 ± 0.037 vs. 0.326 ± 0.032, P = 0.0008) in freshly isolated
glomeruli from the Hi-salt group, compared with the Lo-salt group.
Glomerular expressions of mRNA of NOS3 and TGF-
1 were linearly
correlated (r2 = 0.946, P < 0.0001) (Fig.
3). With glomeruli in culture, production of active TGF-
1 was shown to be increased in rats on the Hi-salt diet (Fig. 4). Consistent with our previous
results (42) and that published by Ohno et al. (25), the increase in
production of TGF-
1 was abrogated by addition of TEA to the medium.
|
|
|
|
NOS3 protein expression of isolated glomeruli in culture was enhanced
by dietary salt (Fig. 5). Addition of
either TEA or a neutralizing antibody to TGF-
to the medium reduced
these values to levels found in the Lo-salt group. Function of NOS3,
determined in the presence of A-23187, was increased in glomeruli from
the Hi-salt group; addition of either TEA or a neutralizing antibody to
TGF-
to the medium also reduced these values to levels found in the
Lo-salt group (Fig. 6). To ensure that the
effect of the antibody to TGF-
was specific, additional Western
blotting experiments were performed following incubation with either
the neutralizing antibody or nonspecific rabbit IgG, 10 µg/ml
(Fig. 7). Nonspecific rabbit IgG
had no effect on NOS3 protein expression. In another study, TGF-
1
was added to the medium in concentrations between 0 and 10 ng/ml. Addition of TGF-
1 to glomeruli from the Hi-salt animals
increased expression of NOS3 but had no effect on glomeruli from the
Lo-salt animals (Fig. 8). Thus, although
TGF-
1 was essential in stimulation of NOS3, dietary salt produced
another factor that permitted TGF-
1 to promote NOS3 expression in
glomeruli.
|
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
TGF-
1 belongs to a family of five multifunctional peptide growth
factors (29). TGF-
1 is produced in the glomerulus (2, 40, 43) and
has come under increasing scrutiny because of the important role this
growth factor plays in glomerular senescence (4, 5, 19, 24, 29,
38-41, 44). We recently examined the potential role of dietary
salt in modifying TGF-
1 expression in the kidney (42). An increase
in dietary salt produced sustained increases in TGF-
1 mRNA and
protein expression in the glomerulus. This effect was inhibited by TEA,
suggesting a shear stress-related mechanism (25, 27). In addition,
previous studies have shown that TGF-
1 directly regulates expression
of NOS3 in bovine endothelial cells in culture (18). Based on these
data and other observations that showed plasma volume increased in rats
on a Hi-salt diet (14), we hypothesized an increase in NO mediated
through TGF-
1 in glomeruli of rats on a Hi-salt diet. One expected
compensation by which NO facilitates salt excretion is the ability of
NO to increase Kf
(15). In the current study, an increase in dietary salt increased NOS3
mRNA and protein expression in freshly isolated glomeruli.
Calcium-dependent NO production was also increased, confirming
augmented NOS3 activity. NOS3 mRNA expression correlated linearly with
TGF-
1 mRNA (Fig. 3). Importantly, both NOS3 protein expression and
function were inhibited by addition of a neutralizing antibody to
TGF-
. Thus the combined data confirmed that dietary salt enhances
expression of TGF-
1 through a TEA-sensitive mechanism, probably
shear stress. In turn, TGF-
1 stimulated glomerular NO production
through NOS3 expression.
The present data provided support for the work of Deng and Baylis (15),
who showed a role of NO in glomerular hemodynamics and glomerular
function. The current studies also suggested one potential source of
augmented production of NO on a Hi-salt diet (33). Enhanced glomerular
NO production produces favorable glomerular hemodynamics to facilitate
salt excretion (3), presumably by relaxation of the mesangial cells.
Certainly, other NOSs, in the kidney and other organs, are also
involved in the increase in NO production by dietary salt (9, 21).
Although our current studies were consistent with the role of changes
in NO in response to dietary salt (8, 16, 33, 37), the data disagree
with two previous reports (21, 34). Mattson and Higgons (21) used
Western blotting to demonstrate that dietary salt increased expression
of NOS3, along with NOS1 and NOS2, in the medulla, but an increase in
NOS3 was not seen in the cortex. As suggested by the authors, one
limitation of their study was the low expression of NOS3 in the cortex
and use of cortical tissue; isolated glomeruli were not examined.
Potentially, these factors obscured any potential differences that
occur in glomeruli in response to dietary salt intake. In the second
study, Singh and associates (34) utilized only semiquantitative RT-PCR
to detect mRNA of NOS3 in microdissected glomeruli. Although this
approach is technically very difficult and contains many pitfalls, we
cannot otherwise explain their negative results. However, pooling large
numbers of isolated glomeruli allowed successful comparison of
steady-state mRNA of NOS3 using standard Northern hybridization
analysis. Although differences between our data and the literature
exist, our study used three different assays to show that steady-state
mRNA, protein levels, and functional activity of NOS3 were all
increased in glomeruli from rats on the Hi-salt diet. Our work provided
in vivo correlation with the previously described role of TGF-
1 in
expression of NOS3 in endothelial cells in culture (18).
The mechanism of regulation of NOS3 by TGF-
1 has been partially
elucidated. Previous studies have shown that TGF-
1 upregulates mRNA
expression of mouse
2(I)
collagen gene through activation of a nuclear factor-1 (NF-1) binding
site in the promoter region (30). Inoue et al. (18)
further demonstrated that TGF-
1 stimulated gene transcription
directly by activation of a similar element in the NOS3 promoter. A
recent intriguing study showed that TGF-
1 regulated CCAAT-binding
transcription factor (CTF-1), the prototypic member of the NF-1 family
of transcription factors, in part, through mobilization of
intracellular calcium stores and activation of calcineurin and
calmodulin-dependent protein kinase IV. Another unidentified
pathway also participates in the process of induction of CTF-1
transcription by TGF-
1 (1). The role of Smad proteins in this signal cascade is currently unclear. Interestingly, although supplemental TGF-
1 increased NOS3 in glomeruli from rats on the Hi-salt diet, TGF-
1 had no effect on NOS3 production in glomeruli from rats on the Lo-salt diet. The reason for this difference is
uncertain at present but may relate to a direct alteration in the
signal transduction cascade known to stimulate NOS3 transcription by
changes in dietary salt.
In summary, dietary salt enhanced glomerular production of TGF-
1
through a TEA-sensitive mechanism. TGF-
1 directly increased NOS3
expression and calcium-dependent NO production. Almost four decades
ago, pioneering work of Meneely and associates (22, 23) demonstrated a
direct link between dietary salt and life span in rats. As dietary salt
was increased from 0.15 to 21%, blood pressure progressively increased
and life span fell. Autopsy studies further suggested findings
compatible with arteriolosclerosis and atherosclerosis, particularly in
the kidneys, as well as glomerular damage. Enhanced glomerular
production of TGF-
1 by dietary salt is one potential mechanism of
damage, although the concomitant increase in NO mitigates this
response. Thus a delicate balance in the glomerulus between TGF-
1
and NOS3 ensures an appropriate hemodynamic action without untoward
effects. However, with endothelial dysfunction, NO production might
fail and facilitate glomerulosclerosis. These concepts provide the
foundation for further investigation.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-46199 and the Office of Research and Development, Medical Research Service, Department of Veterans Affairs.
| |
FOOTNOTES |
|---|
Address for reprint requests: P. W. Sanders, Division of Nephrology, Dept. of Medicine, 642 Lyons-Harrison Research Bldg., Univ. of Alabama at Birmingham, Birmingham, AL 35294-0007.
Received 21 November 1997; accepted in final form 25 February 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Alevizopoulos, A.,
Y. Dusserre,
U. Rüegg,
and
N. Mermod.
Regulation of the transforming growth factor
-responsive transcription factor CTF-1 by calcineurin and calcium/calmodulin-dependent protein kinase IV.
J. Biol. Chem.
272:
23597-23605,
1997
2.
Ando, T.,
S. Okuda,
K. Tamaki,
K. Yoshitomi,
and
M. Fujishima.
Localization of transforming growth factor-
and latent transforming growth factor-
binding protein in rat kidney.
Kidney Int.
47:
733-739,
1995[Medline].
3.
Blantz, R. C.,
F. B. Gabbai,
B. J. Tucker,
T. Yamamoto,
and
C. B. Wilson.
Role of mesangial cell in glomerular response to volume and angiotensin II.
Am. J. Physiol.
264 (Renal Fluid Electrolyte Physiol. 33):
F158-F165,
1993
4.
Border, W. A.,
N. A. Noble,
T. Yamamoto,
J. R. Harper,
Y. Yamaguchi,
M. D. Pierschbacher,
and
E. Ruoslahti.
Natural inhibitor of transforming growth factor-
protects against scarring in experimental kidney disease.
Nature
360:
361-364,
1992[Medline].
5.
Border, W. A.,
S. Okuda,
L. R. Languino,
M. B. Sporn,
and
E. Ruoslahti.
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor
1.
Nature
346:
371-374,
1990[Medline].
6.
Cattell, V.,
T. Cook,
and
S. Moncada.
Glomeruli synthesize nitrite in experimental nephrotoxic nephritis.
Kidney Int.
38:
1056-1060,
1990[Medline].
7.
Chen, G.,
and
D. W. Cheung.
Characterization of acetylcholine-induced membrane hyperpolarization in endothelial cells.
Circ. Res.
70:
257-263,
1992
8.
Chen, P. Y.,
and
P. W. Sanders.
L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats.
J. Clin. Invest.
88:
1559-1567,
1991.
9.
Chen, P. Y.,
and
P. W. Sanders.
Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats.
Hypertension
22:
812-818,
1993
10.
Chen, P. Y.,
P. L. St. John,
K. A. Kirk,
D. R. Abrahamson,
and
P. W. Sanders.
Hypertensive nephrosclerosis in the Dahl/Rapp rat: initial sites of injury and effect of dietary L-arginine administration.
Lab. Invest.
68:
174-184,
1993[Medline].
11.
Chomczynski, P.,
and
N. Sacchi.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:
156-159,
1987[Medline].
12.
Cook, N. S.
The pharmacology of potassium channels and their therapeutic potential.
Trends Pharmacol. Sci.
9:
21-28,
1988[Medline].
13.
Cooke, J. P.,
E. Rossitch, Jr.,
N. A. Andon,
J. Loscalzo,
and
V. J. Dzau.
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator.
J. Clin. Invest.
88:
1663-1671,
1991.
14.
Davis, J. M.,
D. A. Häberle,
and
T. Kawata.
The control of glomerular filtration rate and renal blood flow in chronically volume-expanded rats.
J. Physiol. (Lond.)
402:
473-495,
1988
15.
Deng, A.,
and
C. Baylis.
Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient.
Am. J. Physiol.
264 (Renal Fluid Electrolyte Physiol. 33):
F212-F215,
1993
16.
Deng, X.,
W. J. Welch,
and
C. S. Wilcox.
Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt.
Kidney Int.
46:
639-646,
1994[Medline].
17.
Flanders, K. C.,
T. S. Winokur,
M. G. Holder,
and
M. B. Sporn.
Hyperthermia induces expression of transforming growth factor-
s in rat cardiac cells in vitro and in vivo.
J. Clin. Invest.
92:
404-410,
1993.
18.
Inoue, N.,
R. C. Venema,
H. S. Sayegh,
Y. Ohara,
T. J. Murphy,
and
D. G. Harrison.
Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-
1.
Arterioscler. Thromb. Vasc. Biol.
15:
1255-1261,
1995
19.
Isaka, Y.,
Y. Fujiwara,
N. Ueda,
Y. Kaneda,
T. Kamada,
and
E. Imai.
Glomerulosclerosis induced by in vivo transfection of transforming growth factor-
or platelet-derived growth factor gene into the rat kidney.
J. Clin. Invest.
92:
2597-2601,
1993.
20.
Kitamura, M.,
T. Sütö,
T. Yokoo,
F. Shimizu,
and
L. G. Fine.
Transforming growth factor-
1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells.
J. Immunol.
156:
2964-2971,
1996[Abstract].
21.
Mattson, D. L.,
and
D. J. Higgins.
Influence of dietary sodium intake on renal medullary nitric oxide synthase.
Hypertension
27:
688-692,
1996
22.
Meneely, G. R.,
and
C. O. T. Ball.
Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride.
Am. J. Med.
25:
713-725,
1958[Medline].
23.
Meneely, G. R.,
R. G. Tucker,
W. J. Darby,
and
S. H. Auerbach.
Chronic sodium chloride toxicity: hypertension, renal failure and vascular lesions.
Ann. Intern. Med.
39:
991-998,
1953.
24.
Nakamura, T.,
D. Miller,
E. Ruoslahti,
and
W. A. Border.
Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-
1.
Kidney Int.
41:
1213-1221,
1992[Medline].
25.
Ohno, M.,
J. P. Cooke,
V. J. Dzau,
and
G. H. Gibbons.
Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production.
J. Clin. Invest.
95:
1363-1369,
1995.
26.
Ohno, M.,
G. H. Gibbons,
V. J. Dzau,
and
J. P. Cooke.
Shear stress elevates endothelial cGMP: role of a potassium channel and G protein coupling.
Circulation
88:
193-197,
1993
27.
Olesen, S.-P.,
D. E. Clapham,
and
P. F. Davies.
Haemodynamic shear stress activates a K+ current in vascular endothelial cells.
Nature
331:
168-170,
1988[Medline].
28.
Patel, A.,
S. Layne,
D. Watts,
and
K. A. Kirchner.
L-Arginine administration normalizes pressure natriuresis in the hypertensive Dahl rats.
Hypertension
22:
863-869,
1993
29.
Roberts, A. B.,
and
M. B. Sporn.
Transforming growth factor
.
Adv. Cancer Res.
51:
107-145,
1988[Medline].
30.
Rossi, P.,
G. Karsenty,
A. B. Roberts,
N. S. Roche,
M. B. Sporn,
and
B. de Crombrugghe.
A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-
.
Cell
52:
405-414,
1988[Medline].
31.
Sakai, T.,
and
W. Kriz.
The structural relationship between mesangial cells and basement membrane of the renal glomerulus.
Anat. Embryol. (Berl.)
176:
373-386,
1987[Medline].
32.
Schlondorff, D.
The glomerular mesangial cell: an expanding role for a specialized pericyte.
FASEB J.
1:
272-281,
1987[Abstract].
33.
Shultz, P. J.,
and
J. P. Tolins.
Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide.
J. Clin. Invest.
91:
642-650,
1993.
34.
Singh, I.,
M. Grams,
W.-H. Wang,
T. Yang,
P. Killen,
A. Smart,
J. Schnermann,
and
J. P. Briggs.
Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt.
Am. J. Physiol.
270 (Renal Fluid Electrolyte Physiol. 39):
F1027-F1037,
1996
35.
Tamaki, K.,
S. Okuda,
M. Nakayama,
T. Yanagida,
and
M. Fujishima.
Transforming growth factor-
1 in hypertensive renal injury in Dahl salt-sensitive rats.
J. Am. Soc. Nephrol.
7:
2578-2589,
1996[Abstract].
36.
Tolins, J. P.,
R. M. J. Palmer,
S. Moncada,
and
L. Raij.
Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses.
Am. J. Physiol.
258 (Heart Circ. Physiol. 27):
H655-H662,
1990
37.
Tolins, J. P.,
and
P. J. Shultz.
Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt.
Kidney Int.
46:
230-236,
1994[Medline].
38.
Tomooka, S.,
W. A. Border,
B. C. Marshall,
and
N. A. Noble.
Glomerular matrix accumulation is linked to inhibition of the plasmin protease system.
Kidney Int.
42:
1462-1469,
1992[Medline].
39.
Yamamoto, T.,
T. Nakamura,
N. A. Noble,
E. Ruoslahti,
and
W. A. Border.
Expression of transforming growth factor
is elevated in human and experimental diabetic nephropathy.
Proc. Natl. Acad. Sci. USA
90:
1814-1818,
1993
40.
Yamamoto, T.,
N. A. Noble,
A. H. Cohen,
C. C. Nast,
A. Hishida,
L. I. Gold,
and
W. A. Border.
Expression of transforming growth factor-
isoforms in human glomerular diseases.
Kidney Int.
49:
461-469,
1996[Medline].
41.
Yamamoto, T.,
N. A. Noble,
D. E. Miller,
and
W. A. Border.
Sustained expression of TGF-
1 underlies development of progressive kidney fibrosis.
Kidney Int.
45:
916-927,
1994[Medline].
42.
Ying, W.-Z.,
and
P. W. Sanders.
Dietary salt modulates renal production of transforming growth factor-
in rats.
Am. J. Physiol.
274 (Renal Physiol. 43):
F635-F641,
1998
43.
Yoshioka, K.,
T. Takemura,
K. Murakami,
M. Okada,
S. Hino,
H. Miyamoto,
and
S. Maki.
Transforming growth factor-
protein and mRNA in glomeruli in normal and diseased human kidneys.
Lab. Invest.
68:
154-163,
1993[Medline].
44.
Zhu, L.,
G. A. Herrera,
J. E. Murphy-Ullrich,
Z.-Q. Huang,
and
P. W. Sanders.
Pathogenesis of glomerulosclerosis in light chain deposition disease: role for transforming growth factor-
.
Am. J. Pathol.
147:
375-385,
1995[Abstract].
This article has been cited by other articles:
![]() |
W.-Z. Ying, K. Aaron, and P. W. Sanders Mechanism of dietary salt-mediated increase in intravascular production of TGF-{beta}1 Am J Physiol Renal Physiol, August 1, 2008; 295(2): F406 - F414. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shen, M. Hagiwara, Y.-Y. Yao, L. Chao, and J. Chao Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress Hypertension, May 1, 2008; 51(5): 1358 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cordaillat, A. Fort, A. Virsolvy, J.-L. Elghozi, S. Richard, and B. Jover Nitric oxide pathway counteracts enhanced contraction to membrane depolarization in aortic rings of rats on high-sodium diet Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1557 - R1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bai, S. Ye, R. Mortazavi, V. Campese, and N. D. Vaziri Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney Am J Physiol Renal Physiol, March 1, 2007; 292(3): F974 - F980. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Z. Ying and P. W. Sanders Enhanced expression of EGF receptor in a model of salt-sensitive hypertension Am J Physiol Renal Physiol, August 1, 2005; 289(2): F314 - F321. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-X. Wang and P. W. Sanders Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle Am J Physiol Renal Physiol, January 1, 2005; 288(1): F236 - F242. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Z. Ying and P. W. Sanders The interrelationship between TGF-{beta}1 and nitric oxide is altered in salt-sensitive hypertension Am J Physiol Renal Physiol, November 1, 2003; 285(5): F902 - F908. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Komers and S. Anderson Paradoxes of nitric oxide in the diabetic kidney Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1121 - F1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Schnaper, T. Hayashida, S. C. Hubchak, and A.-C. Poncelet TGF-beta signal transduction and mesangial cell fibrogenesis Am J Physiol Renal Physiol, February 1, 2003; 284(2): F243 - F252. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Loscalzo Salt-Sensitive Hypertension and Inducible Nitric Oxide Synthase: Form-Function Dichotomy of a Coding Region Mutation, Mutatis Mutandis Circ. Res., August 17, 2001; 89(4): 292 - 294. [Full Text] [PDF] |
||||
![]() |
M. J. Solhaug, U. Kullaprawithaya, X. Q. Dong, and K.-W. Dong Expression of endothelial nitric oxide synthase in the postnatal developing porcine kidney Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1269 - R1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Millatt and H. M. Siragy Age-Related Changes in Renal Cyclic Nucleotides and Eicosanoids in Response to Sodium Intake Hypertension, February 1, 2000; 35(2): 643 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Braam Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1551 - R1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Z. Ying, H. Xia, and P. W. Sanders Nitric Oxide Synthase (NOS2) Mutation in Dahl/Rapp Rats Decreases Enzyme Stability Circ. Res., August 17, 2001; 89(4): 317 - 322. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||